Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 14 | $405,522 |
| Sells | 4 | $111,672 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 10 Dec 2024 20:46 | ANTX | AN2 Therapeutics Inc | READNOUR ROBIN SHANE | Director | 06 Dec 2024 | Purchase | 12,711 | 1.445 | 18,367 | I |
| 10 Dec 2024 20:46 | ANTX | AN2 Therapeutics Inc | READNOUR ROBIN SHANE | Director | 06 Dec 2024 | Purchase | 6,517 | 1.4466 | 9,427 | I |
| 10 Dec 2024 20:46 | ANTX | AN2 Therapeutics Inc | READNOUR ROBIN SHANE | Director | 09 Dec 2024 | Purchase | 12,289 | 1.4303 | 17,577 | I |
| 10 Dec 2024 20:46 | ANTX | AN2 Therapeutics Inc | READNOUR ROBIN SHANE | Director | 09 Dec 2024 | Purchase | 18,483 | 1.4287 | 26,407 | I |
| 10 Dec 2024 20:46 | ANTX | AN2 Therapeutics Inc | READNOUR ROBIN SHANE | Director | 10 Dec 2024 | Purchase | 5,000 | 1.4924 | 7,462 | I |
| 10 Dec 2024 20:46 | ANTX | AN2 Therapeutics Inc | READNOUR ROBIN SHANE | Director | 10 Dec 2024 | Purchase | 5,000 | 1.4935 | 7,468 | I |
| 27 Nov 2024 19:07 | ANTX | AN2 Therapeutics Inc | READNOUR ROBIN SHANE | Director | 26 Nov 2024 | Purchase | 12,500 | 1.3934 | 17,418 | I |
| 27 Nov 2024 19:07 | ANTX | AN2 Therapeutics Inc | READNOUR ROBIN SHANE | Director | 26 Nov 2024 | Purchase | 12,500 | 1.3942 | 17,428 | I |
| 27 Nov 2024 19:07 | ANTX | AN2 Therapeutics Inc | READNOUR ROBIN SHANE | Director | 27 Nov 2024 | Purchase | 25,000 | 1.4169 | 35,422 | I |
| 27 Nov 2024 19:07 | ANTX | AN2 Therapeutics Inc | READNOUR ROBIN SHANE | Director | 27 Nov 2024 | Purchase | 25,000 | 1.4167 | 35,418 | I |
| 21 Nov 2024 18:00 | ANTX | AN2 Therapeutics Inc | READNOUR ROBIN SHANE | Director | 19 Nov 2024 | Purchase | 75,000 | 1.0337 | 77,528 | I |
| 21 Nov 2024 18:00 | ANTX | AN2 Therapeutics Inc | READNOUR ROBIN SHANE | Director | 19 Nov 2024 | Purchase | 75,000 | 1.0364 | 77,730 | I |
| 21 Nov 2024 18:00 | ANTX | AN2 Therapeutics Inc | READNOUR ROBIN SHANE | Director | 20 Nov 2024 | Purchase | 25,000 | 1.16 | 29,000 | I |
| 21 Nov 2024 18:00 | ANTX | AN2 Therapeutics Inc | READNOUR ROBIN SHANE | Director | 20 Nov 2024 | Purchase | 25,000 | 1.1548 | 28,870 | I |
| 17 Jan 2024 17:03 | ANTX | AN2 Therapeutics Inc | READNOUR ROBIN SHANE | Director | 12 Jan 2024 | Sale | 719 | 21.91 | 15,753 | I |
| 17 Jan 2024 17:03 | ANTX | AN2 Therapeutics Inc | READNOUR ROBIN SHANE | Director | 12 Jan 2024 | Sale | 706 | 21.92 | 15,476 | I |
| 12 Jan 2024 17:08 | ANTX | AN2 Therapeutics Inc | READNOUR ROBIN SHANE | Director | 10 Jan 2024 | Sale | 1,800 | 21.92 | 39,456 | I |
| 12 Jan 2024 17:08 | ANTX | AN2 Therapeutics Inc | READNOUR ROBIN SHANE | Director | 10 Jan 2024 | Sale | 1,869 | 21.93 | 40,987 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)